AUSTIN, TX / ACCESS Newswire / March 31, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, today announced a ...
Babson and BD are advancing development of the blood testing ecosystem, which includes BD’s capillary-collection technology and Babson’s proprietary automated sample-handling and analytical ...
Capillary blood tests measure p-tau217, GFAP, and NfL without strict temperature controls or immediate centrifugation. Primary care physicians currently have a diagnostic accuracy of ~61% for ...
AUSTIN, Texas and FRANKLIN LAKES, N.J., May 11, 2022 /PRNewswire/ -- Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading ...
BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results